2001•Chinese Journal of Hospital PharmacyRequires access

Study of pharmacokinetics and bioavailability of two dexibuprofen formulations in healthy volunteers

Cao Xiao

Open publisher page 0 citations

Abstract

OBJECTIVE:To study the pharmacokinetics and bioavailability of two dexibuprofen formulations in 20 healthy volunteers.METHODS:A single oral dose containing 300mg dexibuprofen was given to 20 volunteers in randomized crossover study.Concentrations of dexibuprofen in plasma were determined by HPLC.The plasma concentration-time curves of two products were all fitted to a two-compartment model. RESULTS:The pharmacokinetic parameters of capsuls formulation were: T 1/2(2.0±0.7)h, T max(1.7±1.0)h; C max(26.4±5.3)μg·ml-1; CL / F (3.5±0.8)L·h-1; Vd / F (8.0±2.0)L,(8.0±1.7)L; AUC (89.2±19.1)μg·L-1·h. Relative bioavailability was(98.9±10.1)%.CONCLUSIONS:The results of two one-sided tests statistical analysis and rank sum test showed that two formulations were bioequivalent.

About this research paper

What this paper is about

OBJECTIVE:To study the pharmacokinetics and bioavailability of two dexibuprofen formulations in 20 healthy volunteers.METHODS:A single oral dose containing 300mg dexibuprofen was given to 20 volunteers in randomized crossover study.Concentrations of dexibuprofen in plasma were determined by HPLC.The plasma concentration-time curves of two products were all fitted to a two-compartment model. RESULTS:The pharmacokinetic parameters of capsuls formulation were: T 1/2(2.0±0.7)h, T max(1.7±1.0)h; C max(26.4±5.3)μg·ml-1; CL / F (3.5±0.8)L·h-1; Vd / F (8.0±2.0)L,(8.0±1.7)L; AUC (89.2±19.1)μg·L-1·h. Relative bioavailability was(98.9±10.1)%.CONCLUSIONS:The results of two one-sided tests statistical analysis and rank sum test showed that two formulations were bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To study the pharmacokinetics and bioavailability of two dexibuprofen formulations in 20 healthy volunteers.METHODS:A single oral dose containing 300mg dexibuprofen was given to 20 volunteers in randomized crossover study.Concentrations of dexibuprofen in plasma were determined by HPLC.The plasma concentration-time curves of two products were all fitted to a two-compartment model. RESULTS:The pharmacokinetic parameters of capsuls formulation were: T 1/2(2.0±0.7)h, T max(1.7±1.0)h; C max(26.4±5.3)μg·ml-1; CL / F (3.5±0.8)L·h-1; Vd / F (8.0±2.0)L,(8.0±1.7)L; AUC (89.2±19.1)μg·L-1·h. Relative bioavailability was(98.9±10.1)%.CONCLUSIONS:The results of two one-sided tests statistical analysis and rank sum test showed that two formulations were bioequivalent.

Key concepts: Bioavailability, Bioequivalence, Pharmacokinetics, Crossover study, Chemistry, Plasma concentration, Pharmacology, Chromatography

Related papers

Back to paper searchBrowse research topicsOriginal source
Study of pharmacokinetics and bioavailability of two dexibuprofen formulations in healthy volunteers — Research Paper | ScholarLens